These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28810121)
1. Comparative Proteomic and Transcriptomic Analysis of Follistatin-Induced Skeletal Muscle Hypertrophy. Barbé C; Bray F; Gueugneau M; Devassine S; Lause P; Tokarski C; Rolando C; Thissen JP J Proteome Res; 2017 Oct; 16(10):3477-3490. PubMed ID: 28810121 [TBL] [Abstract][Full Text] [Related]
2. Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscle. Salzler RR; Shah D; Doré A; Bauerlein R; Miloscio L; Latres E; Papadopoulos NJ; Olson WC; MacDonald D; Duan X Proteomics; 2016 Jul; 16(14):2019-27. PubMed ID: 27214824 [TBL] [Abstract][Full Text] [Related]
3. Role of IGF-I in follistatin-induced skeletal muscle hypertrophy. Barbé C; Kalista S; Loumaye A; Ritvos O; Lause P; Ferracin B; Thissen JP Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E557-67. PubMed ID: 26219865 [TBL] [Abstract][Full Text] [Related]
4. Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy. Lee YS; Lehar A; Sebald S; Liu M; Swaggart KA; Talbot CC; Pytel P; Barton ER; McNally EM; Lee SJ Hum Mol Genet; 2015 Oct; 24(20):5711-9. PubMed ID: 26206886 [TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249 [TBL] [Abstract][Full Text] [Related]
6. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice. Tsuchida K Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572 [TBL] [Abstract][Full Text] [Related]
7. miRNA transcriptome of hypertrophic skeletal muscle with overexpressed myostatin propeptide. Javed R; Jing L; Yang J; Li X; Cao J; Zhao S Biomed Res Int; 2014; 2014():328935. PubMed ID: 25147795 [TBL] [Abstract][Full Text] [Related]
8. p21-Activated Kinase 1 Is Permissive for the Skeletal Muscle Hypertrophy Induced by Myostatin Inhibition. Barbé C; Loumaye A; Lause P; Ritvos O; Thissen JP Front Physiol; 2021; 12():677746. PubMed ID: 34220542 [TBL] [Abstract][Full Text] [Related]
9. RNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptide. Miao Y; Yang J; Xu Z; Jing L; Zhao S; Li X Int J Mol Sci; 2015 Apr; 16(4):7976-94. PubMed ID: 25860951 [TBL] [Abstract][Full Text] [Related]
10. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Gilson H; Schakman O; Kalista S; Lause P; Tsuchida K; Thissen JP Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E157-64. PubMed ID: 19435857 [TBL] [Abstract][Full Text] [Related]
11. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice. Matsakas A; Foster K; Otto A; Macharia R; Elashry MI; Feist S; Graham I; Foster H; Yaworsky P; Walsh F; Dickson G; Patel K Neuromuscul Disord; 2009 Jul; 19(7):489-99. PubMed ID: 19541486 [TBL] [Abstract][Full Text] [Related]
12. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy. Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499 [TBL] [Abstract][Full Text] [Related]
13. Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure. Lima AR; Martinez PF; Okoshi K; Guizoni DM; Zornoff LA; Campos DH; Oliveira SA; Bonomo C; Pai-Silva MD; Okoshi MP Int J Exp Pathol; 2010 Feb; 91(1):54-62. PubMed ID: 20002838 [TBL] [Abstract][Full Text] [Related]
14. Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue. Wang L; Zheng ZG; Meng L; Zhu L; Li P; Chen J; Yang H Cell Biol Toxicol; 2021 Jun; 37(3):441-460. PubMed ID: 33034787 [TBL] [Abstract][Full Text] [Related]
15. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy. Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027 [TBL] [Abstract][Full Text] [Related]
16. The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs. Chang F; Fang R; Wang M; Zhao X; Chang W; Zhang Z; Li N; Meng Q Transgenic Res; 2017 Feb; 26(1):25-36. PubMed ID: 27787698 [TBL] [Abstract][Full Text] [Related]
18. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643 [TBL] [Abstract][Full Text] [Related]
19. Myostatin inhibition promotes fast fibre hypertrophy but causes loss of AMP-activated protein kinase signalling and poor exercise tolerance in a model of limb-girdle muscular dystrophy R1/2A. Kramerova I; Marinov M; Owens J; Lee SJ; Becerra D; Spencer MJ J Physiol; 2020 Sep; 598(18):3927-3939. PubMed ID: 33460149 [TBL] [Abstract][Full Text] [Related]
20. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis. Nakatani M; Kokubo M; Ohsawa Y; Sunada Y; Tsuchida K Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E543-53. PubMed ID: 21205933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]